Canada studies asthma drug Xolair risks
Posted on: Thursday, 13 August 2009, 11:36 CDT
Canadian officials say they are conducting a safety review of a potential link between the asthma drug Xolair and increased risk of cardiovascular problems.
Health Canada said the review follows the interim findings of an ongoing U.S. study that suggests an increase in such problems by patients treated with Xolair (omalizumab), including heart attacks, abnormal heart rhythms, heart failure, fainting, mini-strokes and blood clots.
In Canada, Xolair is indicated for the treatment of asthma in people 12 years old and older who have moderate to severe persistent asthma, who react to airborne allergens and whose symptoms are not adequately controlled with inhaled corticosteroids.
Although Health Canada recommends patients should not stop taking Xolair without first speaking with their doctor, the federal agency also urges patients to contact their health care professional if they have any concerns about the medicines they are taking.
Xolair is manufactured by Novartis Pharmaceuticals Canada.
Source: United Press International
Related Articles
- Study Demonstrated Asthma Patients Had Better Overall Results With Oral Controllers
- National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences
- Home Health Monitoring Systems for Heart Failure Patients Emerge As the Healthcare Industry Moves From Intervention-Based Care to Preventive Care
- St. Jude Medical Announces Japanese Approval of CRT-D Products to Treat Heart Failure Patients
- 500,000 Inhalers to Be Distributed to Uninsured Asthma Patients Across the Country
- ALR Technologies Receives FCC License for Their Patient Health Management Compliance System, the Constant Health Companion
- Heart Transplant Patient Reports Significant Results With Medication and Treatment Compliance Using the ALRT500 Home Health Management System
- FDA OKs drug for heart transplant patients
- Lowering BP With Medication Provides Unexpected Benefits for Heart Disease Patients With 'Normal' Blood Pressure
- Drug May Help Heart Transplant Patients
 |
 |
User Comments (0)
RSS Feeds